Scheideler MA[au] - Search Results

Year	Number of Results
1983	1
1984	1
1986	2
1989	1
1990	1
1991	3
1992	2
1995	1
1996	2
1997	1
1998	3
2000	2
2001	3
2002	2
2003	5
2004	2
2005	1
2017	1
2018	2
2021	0

1

PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models.

Zhao HT, Damle S, Ikeda-Lee K, Kuntz S, Li J, Mohan A, Kim A, Hung G, Scheideler MA, Scherer SS, Svaren J, Swayze EE, Kordasiewicz HB. Zhao HT, et al. Among authors: scheideler ma. J Clin Invest. 2018 Jan 2;128(1):359-368. doi: 10.1172/JCI96499. Epub 2017 Dec 4. J Clin Invest. 2018. PMID: 29202483 Free PMC article.

2

Recent advances in the development of dopamine D(3) receptor agonists and antagonists.

Crider AM, Scheideler MA. Crider AM, et al. Among authors: scheideler ma. Mini Rev Med Chem. 2001 May;1(1):89-99. doi: 10.2174/1389557013407287. Mini Rev Med Chem. 2001. PMID: 12369994 Review.

3

Myelinated axons fail to develop properly in a genetically authentic mouse model of Charcot-Marie-Tooth disease type 2E.

Lancaster E, Li J, Hanania T, Liem R, Scheideler MA, Scherer SS. Lancaster E, et al. Among authors: scheideler ma. Exp Neurol. 2018 Oct;308:13-25. doi: 10.1016/j.expneurol.2018.06.010. Epub 2018 Jun 22. Exp Neurol. 2018. PMID: 29940160

4

4-Amino-3(2H)-pyridazinones bearing arylpiperazinylalkyl groups and related compounds: synthesis and antinociceptive activity.

Piaz VD, Vergelli C, Giovannoni MP, Scheideler MA, Petrone G, Zaratin P. Piaz VD, et al. Among authors: scheideler ma. Farmaco. 2003 Nov;58(11):1063-71. doi: 10.1016/S0014-827X(03)00162-9. Farmaco. 2003. PMID: 14572856

5

Schwann cell overexpression of the GPR7 receptor in inflammatory and painful neuropathies.

Zaratin PF, Quattrini A, Previtali SC, Comi G, Hervieu G, Scheideler MA. Zaratin PF, et al. Among authors: scheideler ma. Mol Cell Neurosci. 2005 Jan;28(1):55-63. doi: 10.1016/j.mcn.2004.08.010. Mol Cell Neurosci. 2005. PMID: 15607941

6

Glycerophosphate acyltransferase from Escherichia coli.

Scheideler MA, Bell RM. Scheideler MA, et al. Methods Enzymol. 1992;209:55-63. doi: 10.1016/0076-6879(92)09007-p. Methods Enzymol. 1992. PMID: 1495435 No abstract available.

7

Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system.

Larminie C, Murdock P, Walhin JP, Duckworth M, Blumer KJ, Scheideler MA, Garnier M. Larminie C, et al. Among authors: scheideler ma. Brain Res Mol Brain Res. 2004 Mar 17;122(1):24-34. doi: 10.1016/j.molbrainres.2003.11.014. Brain Res Mol Brain Res. 2004. PMID: 14992813

8

PTH2 receptor-mediated inhibitory effect of parathyroid hormone and TIP39 on cell proliferation.

Misiano P, Scott BB, Scheideler MA, Garnier M. Misiano P, et al. Among authors: scheideler ma. Eur J Pharmacol. 2003 May 16;468(3):159-66. doi: 10.1016/s0014-2999(03)01673-x. Eur J Pharmacol. 2003. PMID: 12754053

9

Phospholipid dependence of homogeneous, reconstituted sn-glycerol-3-phosphate acyltransferase of Escherichia coli.

Scheideler MA, Bell RM. Scheideler MA, et al. J Biol Chem. 1989 Jul 25;264(21):12455-61. J Biol Chem. 1989. PMID: 2663857 Free article.

10

Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111).

Zaratin PF, Petrone G, Sbacchi M, Garnier M, Fossati C, Petrillo P, Ronzoni S, Giardina GA, Scheideler MA. Zaratin PF, et al. Among authors: scheideler ma. J Pharmacol Exp Ther. 2004 Feb;308(2):454-61. doi: 10.1124/jpet.103.055848. Epub 2003 Oct 30. J Pharmacol Exp Ther. 2004. PMID: 14593080

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results